1-6 of 6
Chiara Paoli, BiSci
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Changing Patterns, and Clinical Correlates, of Mutations in Patients with Myelofibrosis over Treatment with Ruxolitinib or Hydroxyurea

Alessandro M. Vannucchi, Annalisa Pacilli, PhD, Giada Rotunno, MSc, PhD, Francesco Mannelli, Chiara Paoli, BiSci, Carmela Mannarelli, MSc, PhD, Annalisa Franci, RN, Tiziana Fanelli, BiSc, Alessandro Pancrazzi, PhD, Francesca Gesullo, MSc, Giuditta Corbizi Fattori, BiSc, Alberto Bosi, MD, Paola Guglielmelli, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4195.
https://doi.org/10.1182/blood.V130.Suppl_1.4195.4195
Published: 2017
Journal Articles

A Distinct Mutation Profile Might Contribute to the Dismal Outcome of Triple Negative Patients with Primary Myelofibrosis

Paola Guglielmelli, MD PhD, Giada Rotunno, MSc, PhD, Annalisa Pacilli, PhD, Carmela Mannarelli, MSc, PhD, Chiara Paoli, BiSci, Elisa Rumi, MD, Vittorio Rosti, MD, Tiziana Fanelli, BiSc, Annalisa Franci, RN, Francesco Mannelli, Michelle Nahas, PhD, Jie He, PhD, Nikita Agarwal, PhD, Alessandro Rambaldi, MD Prof, Tariq Mughal, FRCP, Francesco Passamonti, MD, Giovanni Barosi, MD, Tiziano Barbui, MD, Mario Cazzola, MD, Alessandro M. Vannucchi
Journal: Blood
Blood (2017) 130 (Supplement 1): 1657.
https://doi.org/10.1182/blood.V130.Suppl_1.1657.1657
Published: 2017
Journal Articles

Impact Of Prognostically Detrimental Mutations ( ASXL1, EZH2, SRSF2, IDH1/2 ) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II

Paola Guglielmelli, PhD MD, Flavia Biamonte, BiSci, PhD, Lisa Pieri, MD PhD, Giada Rotunno, BiSci, Chiara Paoli, BiSci, Rajmonda Fjerza, MD, Enrico Tagliafico, MD PhD, Rossella Manfredini, PhD, Valentina Artusi, MSc, Elena Tenedini, PhD, Lucia Artuso, PhD, Isabella Bernardis, Viktoriya Stalbovskaya, PhD, Matthew Squires, PhD, Claire N Harrison, DM, FRCP, FRCPath, Alessandro M Vannucchi, MD
Journal: Blood
Blood (2013) 122 (21): 107.
https://doi.org/10.1182/blood.V122.21.107.107
Published: 2013
Journal Articles

A Phase 2 Study Of Ruxolitinib In Patients With Splanchnic Vein Thrombosis Associated With Myeloproliferative Neoplasm. Preliminary Results

Lisa Pieri, MD, PhD, Chiara Paoli, BiSci, Paola Guglielmelli, PhD MD, Rajmonda Fjerza, MD, Umberto Arena, MD, Fabio Marra, MD, Stefano Colagrande, MD, Fabio Mori, MD, Roberto Marchioli, MD, Raffaella Pioggiarella, PharmD, Marco Ruggeri, MD, Ilaria Nichele, MD, Guido Finazzi, MD, Maria Luisa Ferrari, MD, Vittorio Rosti, MD, Valerio De Stefano, MD, Elisa Rumi, MD, Carmela Mannarelli, BiSci, Tiziana Fanelli, BiSci, Alberto Bosi, Alessandro Rambaldi, MD, Giovanni Barosi, MD, Mario Cazzola, MD, Tiziano Barbui, MD, Alessandro M Vannucchi, MD
Journal: Blood
Blood (2013) 122 (21): 1583.
https://doi.org/10.1182/blood.V122.21.1583.1583
Published: 2013
Journal Articles

Inhibitors of PI3K/Akt and/or mTOR Inhibit the Growth of Cells of Myeloproliferative Neoplasms and Synergize with JAK2 Inhibitor and Interferon,

Alessandro M. Vannucchi, MD, Costanza Bogani, PhD, Niccolò Bartalucci, BiSc, Lorenzo Tozzi, BiSci, Serena Martinelli, BiSci, Paola Guglielmelli, MD, PhD, Chiara Paoli, BiSci, Lisa Pieri, MD, Alberto Bosi, MD
Journal: Blood
Blood (2011) 118 (21): 3835.
https://doi.org/10.1182/blood.V118.21.3835.3835
Published: 2011
Journal Articles

Prognostic Impact of EZH2 and ASXL1 Mutation in Myelofibrosis

Paola Guglielmelli, MD, PhD, Flavia Biamonte, BiSc, Johannah Score, Claire Hidalgo-Curtis, PhD, Francisco Cervantes, MD, PhD, Margherita Maffioli, MD, Tiziana Fanelli, BiSci, Thomas Ernst, MD, Nils Winkelman, MD, Amy V Jones, PhD, Katerina Zoi, MD, PhD, Andreas Reiter, MD, Andrew Duncombe, MD, Laura Villani, Biol Sci, Chiara Paoli, BiSci, Alberto Bosi, MD, Giovanni Barosi, MD, Nicholas C.P. Cross, PhD, Alessandro M. Vannucchi, MD
Journal: Blood
Blood (2011) 118 (21): 2811.
https://doi.org/10.1182/blood.V118.21.2811.2811
Published: 2011